Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects
NCT05661903Phase 2Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2023
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2, randomised trial (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Supraexcitability at 6 weeks. Started Jun 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05661903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05661903.